Folates and S-adenosylmethionine for major depressive disorder (Q38023888)

27 August 2017

title

Folates and S-adenosylmethionine for major depressive disorder (English)

1 reference

27 August 2017

George I Papakostas

1

1 reference

27 August 2017

Clair F Cassiello

series ordinal

2

1 reference

27 August 2017

Nadia Iovieno

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

Canadian Journal of Psychiatry

27 August 2017

published in

1 reference

27 August 2017

volume

57

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

406-413

1 reference

Neuropharmacology of S-adenosyl-L-methionine

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

S-adenosyl-methionine in depression: A comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Homocysteine, folate, methylation, and monoamine metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Depression and folate status in the US Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Folate, vitamin B12, and homocysteine in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Impact of suppression of thyroxine on folate status during acute antidepressant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

What are the psychiatric manifestations of vitamin B12 deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

B complex vitamin patterns in geriatric and young adult inpatients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

One-carbon metabolism disturbances in affective disorders. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Late-onset depression: genetic, vascular and clinical contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Modification by two genes of associations between general somatic health and incident depressive syndrome in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Homocysteine and depression in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Meta-analyses of genetic studies on major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Folates and psychiatric disorders. Clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

An open trial of methyltetrahydrofolate in elderly depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Enhancement of recovery from psychiatric illness by methylfolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Folic Acid for the Prevention of Colorectal Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Transcranial electrical stimulation in patients with apallic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

The switch mechanism and the bipolar/unipolar dichotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection Effect of parenteral treatment with SAMe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700703

10.1177/070674371205700703

21 January 2018

Identifiers

DOI

0 references

1 reference